Advanced nanomaterials as sample technique for bio-analysis

N Sun, H Yu, H Wu, X Shen, C Deng - TrAC Trends in Analytical Chemistry, 2021 - Elsevier
The biological compositions including cells, proteins/peptides, nucleic acids, extracellular
vesicles (EVs) and metabolites are no doubt closely related to almost all physiological and …

Dormant cancer cells: programmed quiescence, senescence, or both?

K Truskowski, SR Amend, KJ Pienta - Cancer and Metastasis Reviews, 2023 - Springer
Metastasis is the overwhelming driver of cancer mortality, accounting for the majority of
cancer deaths. Many patients present with metastatic relapse years after eradication of the …

Serum exosome microRNA as a minimally-invasive early biomarker of AML

NI Hornick, J Huan, B Doron, NA Goloviznina… - Scientific reports, 2015 - nature.com
Relapse remains the major cause of mortality for patients with Acute Myeloid Leukemia
(AML). Improved tracking of minimal residual disease (MRD) holds the promise of timely …

State-of-the-art nanotechnologies for the detection, recovery, analysis and elimination of liquid biopsy components in cancer

M Zhao, D Mi, BE Ferdows, Y Li, R Wang, J Li, D Patel… - Nano Today, 2022 - Elsevier
Liquid biopsy allows for the quick and noninvasive detection of tumor-associated
components. Various liquid biopsy components, which include circulating tumor cells, tumor …

Advances in circulating tumor DNA analysis

S Perakis, M Auer, J Belic, E Heitzer - Advances in clinical chemistry, 2017 - Elsevier
The analysis of cell-free circulating tumor DNA (ctDNA) is a very promising tool and might
revolutionize cancer care with respect to early detection, identification of minimal residual …

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer

X Huang, P Gao, Y Song, J Sun, X Chen, J Zhao, H Xu… - BMC cancer, 2015 - Springer
Background The prognostic value of circulating tumor cells (CTCs) detected with the
CellSearch System in patients with colorectal cancer (CRC) is controversial. The aim of our …

Cell‐free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer

KLG Spindler, AL Appelt, N Pallisgaard… - … Journal of Cancer, 2014 - Wiley Online Library
The purpose was to investigate total cell‐free DNA (cfDNA) in colorectal cancer (CRC)
patients during treatment with second‐line chemotherapy and in healthy controls and …

Exploring the clinical utility of pancreatic cancer circulating tumor cells

D Yeo, A Bastian, H Strauss, P Saxena… - International Journal of …, 2022 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is the most frequent pancreatic cancer type,
characterized by a dismal prognosis due to late diagnosis, frequent metastases, and limited …

Translational significance for tumor metastasis of tumor-associated macrophages and epithelial–mesenchymal transition

W Song, R Mazzieri, T Yang, GC Gobe - Frontiers in immunology, 2017 - frontiersin.org
The tumor microenvironment determines development and progression of many cancers.
Epithelial–mesenchymal transition (EMT) is fundamental to tumor progression and …

Cell‐free DNA in metastatic colorectal cancer: a systematic review and meta‐analysis

KLG Spindler, AK Boysen, N Pallisgård… - The …, 2017 - academic.oup.com
Background Circulating DNA can be detected and quantified in the blood of cancer patients
and used for detection of tumor‐specific genetic alterations. The clinical utility has been …